63 related articles for article (PubMed ID: 15186528)
1. Conserved neutralizing epitopes of HIV type 1 CRF01_AE against primary isolates in long-term nonprogressors.
Sreepian A; Srisurapanon S; Horthongkham N; Tunsupasawasdikul S; Kaoriangudom S; Khusmith S; Sutthent R
AIDS Res Hum Retroviruses; 2004 May; 20(5):531-42. PubMed ID: 15186528
[TBL] [Abstract][Full Text] [Related]
2. Antibodies to conserved epitopes of the HIV-1 envelope in sera from long-term non-progressors: prevalence and association with neutralizing activity.
Braibant M; Brunet S; Costagliola D; Rouzioux C; Agut H; Katinger H; Autran B; Barin F
AIDS; 2006 Oct; 20(15):1923-30. PubMed ID: 16988513
[TBL] [Abstract][Full Text] [Related]
3. Common antibody dependent cell mediated cytotoxicity (ADCC) antibody epitopes of HIV-1 CRF01_AE Env and Gag in early HIV-1 infected individuals.
Sangjan S; Ampol S; Tabprasit S; Horthongkham N; Chuenchitra T; Ekpo P; Kantakamalakul W
Asian Pac J Allergy Immunol; 2019 Mar; 37(1):43-50. PubMed ID: 29602284
[TBL] [Abstract][Full Text] [Related]
4. Identifiable biomarker and treatment development using HIV-1 long term non-progressor sera.
Hao Y; Bai G; Wang J; Zhao L; Sutherland K; Cai J; Cao C
BMC Immunol; 2015 Apr; 16():25. PubMed ID: 25927639
[TBL] [Abstract][Full Text] [Related]
5. Anti-V3/Glycan and Anti-MPER Neutralizing Antibodies, but Not Anti-V2/Glycan Site Antibodies, Are Strongly Associated with Greater Anti-HIV-1 Neutralization Breadth and Potency.
Jacob RA; Moyo T; Schomaker M; Abrahams F; Grau Pujol B; Dorfman JR
J Virol; 2015 May; 89(10):5264-75. PubMed ID: 25673728
[TBL] [Abstract][Full Text] [Related]
6. Mimotopes selected with antibodies from HIV-1-neutralizing long-term non-progressor plasma.
Humbert M; Antoni S; Brill B; Landersz M; Rodes B; Soriano V; Wintergerst U; Knechten H; Staszewski S; von Laer D; Dittmar MT; Dietrich U
Eur J Immunol; 2007 Feb; 37(2):501-15. PubMed ID: 17236253
[TBL] [Abstract][Full Text] [Related]
7. Characterization of broadly neutralizing antibody responses to HIV-1 in a cohort of long term non-progressors.
González N; McKee K; Lynch RM; Georgiev IS; Jimenez L; Grau E; Yuste E; Kwong PD; Mascola JR; Alcamí J
PLoS One; 2018; 13(3):e0193773. PubMed ID: 29558468
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive investigation of common antibody-dependent cell-mediated cytotoxicity antibody epitopes of HIV-1 CRF01_AE gp120.
Ampol S; Pattanapanyasat K; Sutthent R; Permpikul P; Kantakamalakul W
AIDS Res Hum Retroviruses; 2012 Oct; 28(10):1250-8. PubMed ID: 22288892
[TBL] [Abstract][Full Text] [Related]
9. The degree of HIV-1 amino acid variability is strictly related to different disease progression rates.
Scutari R; Faieta M; D'Arrigo R; Fabeni L; Mussini C; Cossarizza A; Casoli C; Perno CF; Svicher V; Alteri C; Aquaro S
Virus Genes; 2018 Aug; 54(4):493-501. PubMed ID: 29777446
[TBL] [Abstract][Full Text] [Related]
10. Comparative studies on neutralisation of primary HIV-1 isolates by human sera and rabbit anti-V3 peptide sera.
Lawoko AL; Johansson B; Hjalmarsson S; Christensson B; Ljungberg B; Al-Khalili L; Sjölund M; Pipkorn R; Fenyö EM; Blomberg J
J Med Virol; 1999 Oct; 59(2):169-79. PubMed ID: 10459152
[TBL] [Abstract][Full Text] [Related]
11. The role of conventional antibodies targeting the CD4 binding site and CD4-induced epitopes in the control of HIV-1 CRF01_AE viruses.
Thida W; Kuwata T; Maeda Y; Yamashiro T; Tran GV; Nguyen KV; Takiguchi M; Gatanaga H; Tanaka K; Matsushita S
Biochem Biophys Res Commun; 2019 Jan; 508(1):46-51. PubMed ID: 30470571
[TBL] [Abstract][Full Text] [Related]
12. HIV-1 neutralization by monoclonal antibody against conserved region 2 and patterns of epitope exposure on the surface of native viruses.
Sreepian A; Permmongkol J; Kantakamalakul W; Siritantikorn S; Tanlieng N; Sutthent R
J Immune Based Ther Vaccines; 2009 Oct; 7():5. PubMed ID: 19821992
[TBL] [Abstract][Full Text] [Related]
13. HIV-1 subtype B Tat gene activities and disease progression in HIV-1 CRF01_AE infection.
Niyasom C; Horthongkham N; Sreephiang A; Kantakamalakul W; Louisirirotchanakul S; Chuenchitra T; Sutthent R
Southeast Asian J Trop Med Public Health; 2009 Jul; 40(4):748-58. PubMed ID: 19842409
[TBL] [Abstract][Full Text] [Related]
14. High level serum neutralizing antibody against HIV-1 in Chinese long-term non-progressors.
Wang Q; Shang H; Han X; Zhang Z; Jiang Y; Wang Y; Dai D; Diao Y
Microbiol Immunol; 2008 Apr; 52(4):209-15. PubMed ID: 18426395
[TBL] [Abstract][Full Text] [Related]
15. [Distribution of recombinant human immunodeficiency virus type-1 CRF01_AE strains in China and its sequence variations in the env V3-C3 region].
Xing H; Liang H; Wan ZY; Chen X; Wei M; Ma PF; Guan Q; Quan Y; Hong KX; Shao YM
Zhonghua Yu Fang Yi Xue Za Zhi; 2004 Sep; 38(5):300-4. PubMed ID: 15498240
[TBL] [Abstract][Full Text] [Related]
16. Distribution of linear antigenic epitopes on GP120 encoded in sibling clones of novel New York HIV-1 subtype B isolates.
Riley JP; Pestano GA; Harewood K; Alfred LJ; Guyden J; Boto WM
Cell Mol Biol (Noisy-le-grand); 1995; 41 Suppl 1():S83-91. PubMed ID: 8574151
[TBL] [Abstract][Full Text] [Related]
17. Epitopes corresponding to the envelope genetic subtype are present on the surface of free virions of HIV-1 group M primary isolates and can be detected in neutralization assays with extended incubation phases.
Davis D; Donners H; Willems B; Vermoesen T; Heyndrickx L; Colebunders R; van der Groen G
J Med Virol; 2003 Nov; 71(3):332-42. PubMed ID: 12966537
[TBL] [Abstract][Full Text] [Related]
18. Specific antibody responses to vaccination with bivalent CM235/SF2 gp120: detection of homologous and heterologous neutralizing antibody to subtype E (CRF01.AE) HIV type 1.
Kim JH; Pitisuttithum P; Kamboonruang C; Chuenchitra T; Mascola J; Frankel SS; DeSouza MS; Polonis V; McLinden R; Sambor A; Brown AE; Phonrat B; Rungruengthanakit K; Duliege AM; Robb ML; McNeil J; Birx DL;
AIDS Res Hum Retroviruses; 2003 Sep; 19(9):807-16. PubMed ID: 14585211
[TBL] [Abstract][Full Text] [Related]
19. Comparison of HIV Type 1 ADA gp120 monomers versus gp140 trimers as immunogens for the induction of neutralizing antibodies.
Kim M; Qiao ZS; Montefiori DC; Haynes BF; Reinherz EL; Liao HX
AIDS Res Hum Retroviruses; 2005 Jan; 21(1):58-67. PubMed ID: 15665645
[TBL] [Abstract][Full Text] [Related]
20. Coreceptor tropism determined by genotypic assay in HIV-1 circulating in Thailand, where CRF01_AE predominates.
Phuphuakrat A; Phawattanakul S; Pasomsub E; Kiertiburanakul S; Chantratita W; Sungkanuparph S
HIV Med; 2014 May; 15(5):269-75. PubMed ID: 24215399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
